Metabolism and Target Organ Damage
All Journals
Search Log In
Editors-in-Chief: Amedeo Lonardo, Youfei Guan
Indexing: ESCI, Scopus, CAS, Dimensions, Lens, CNKI, ASCI,
Median time to first editorial decision: 6 days
Home Articles Special Topics Volumes Webinars Interviews
Metabolism and Target Organ Damage
Search Submit
Editors-in-Chief: Amedeo Lonardo, Youfei Guan
Median time to first editorial decision: 6 days
Home Articles Special Topics Volumes Webinars Interviews

Metabolism and Target Organ Damage

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Sarcopenia in the setting of nonalcoholic fatty liver

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Combined lifestyle and type 2 diabetes mellitus among women with a history of GDM or HDP

SGLT2 inhibitor and lipid metabolism in coronary artery disease with type 2 diabetes across glycemic control status

Articles

Most Recent | Most Viewed | Most Downloaded

Maintenance of weight reduction in obesity: what does the SURMOUNT-MAINTAIN actually resolve?

Andrej Janez, ...Manfredi Rizzo
Open Access Commentary DOI: 10.20517/mtod.2026.143 16 Oct 2026
Views: Downloads:
Download PDF

Continuous glucose monitoring in insulin-treated diabetes beyond glycemic control and towards precision metabolic care

Charlotte Delrue, ...Marijn M. Speeckaert
Open Access Commentary DOI: 10.20517/mtod.2026.169 9 Oct 2026
Views: Downloads:
Download PDF

Follistatin-like 1 and galectin-1 as potential exerkines: a cross-study evaluation of tissue attribution and implications for metabolic disease

Timothy Zhang, ...Hash Brown Taha
Open Access Commentary DOI: 10.20517/mtod.2026.147 9 Oct 2026
Views: Downloads:
Download PDF

Emerging pharmacological treatment options for MASLD/MASH

Jimena Soto-Campillo, ...Norberto C. Chávez-Tapia
Open Access Review DOI: 10.20517/mtod.2026.124 9 Oct 2026
Views: Downloads:
Download PDF

Obesity-induced mesenchymal stem cell dysfunction: from molecular mechanisms to therapeutic strategies

Ahmed Elmaraezy, ...Lilach O. Lerman
Open Access Review DOI: 10.20517/mtod.2026.85 8 Oct 2026
Views: Downloads:
Download PDF

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review

Amedeo LonardoAmedeo Lonardo
Open Access Review DOI: 10.20517/mtod.2024.07 6 Apr 2024
Views: Downloads:
Download PDF

Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease

Amedeo LonardoAmedeo Lonardo, ... Ralf WeiskirchenRalf Weiskirchen
Open Access Review DOI: 10.20517/mtod.2024.42 14 Nov 2024
Views: Downloads:
Download PDF

MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?

Christopher D. ByrneChristopher D. Byrne, Giovanni TargherGiovanni Targher
Open Access Perspective DOI: 10.20517/mtod.2024.06 26 Feb 2024
Views: Downloads:
Download PDF

Coming soon.

For Reviewers

Peer Review Guidelines
For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Themed Collections
metabolic syndrome
kidney
atherosclerosis
endocrine disorder
NAFLD
diabetes
MAFLD
adipose tissue
obesity
obesity
metabolism
fatty liver
steatosis
fibrosis
cardiovascular
insulin resistance
hypertension
metabolomics
precision medicine
hypertriglyceridemia
Topic: Metabolic Heterogeneity in Childhood Obesity and Preventive Strategy
Topic: OAE 10th Anniversary Commemorative Special Issue: Metabolic Dysfunction and Target Organ Damage — Emerging Insights and Future Perspectives
Topic: Emerging Mechanisms and Therapeutic Strategies in Diabetic Cardiovascular Disease
Volume 6, Issue 2
Volume 6, Issue 1
Volume 5, Issue 4
Volume 5, Issue 3
Volume 5, Issue 2
Volume 5, Issue 1
Volume 4, Issue 4
Volume 4, Issue 3
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 4
Volume 3, Issue 3
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Volume 1, Issue 2
Volume 2, Issue 1
Volume 1, Issue 1
Congratulations: 84 Editorial Board Members of Metabolism and Target Organ Damage Named Among the World's Top 2% of Scientists in 2026
Congratulations: 84 Editorial Board Members of Metabolism and Target Organ Damage Named Among the World's Top 2% of Scientists in 2026
Non-invasive Testing in MetALD: From Diagnosis to Clinical Trials
How steatosis, fibrosis, and alcohol biomarkers reshape assessment and drug development in metabolic dysfunction-associated alcohol-related liver disease
M&TOD Maintains Impact Factor 3.9 in Latest JCR Rankings
Ranked 73/198 in Endocrinology & Metabolism (Q2, 30%), demonstrating stable performance and sustained academic influence in the latest Clarivate evaluation.
How Lipid Metabolism Drives Liver Regeneration
A mini review highlights the key roles of lipid droplets, lipophagy, and ER stress in orchestrating hepatic repair
Sex Differences in MASLD: Biological Determinants and Clinical Outcomes
Explore how male and female biology shapes MASLD risk and treatment - read more inside!

Effect of cofactors on NAFLD/NASH and MAFLD - a paradigm illustrating the pathomechanics of organ dysfunction

Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality

Concise review: gamma-glutamyl transferase - evolution from an indiscriminate liver test to a biomarker of cardiometabolic risk

Sarcopenia in the setting of nonalcoholic fatty liver

Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms

Combined lifestyle and type 2 diabetes mellitus among women with a history of GDM or HDP

SGLT2 inhibitor and lipid metabolism in coronary artery disease with type 2 diabetes across glycemic control status

Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review
Amedeo LonardoAmedeo Lonardo
Open Access | Review | 6 Apr 2024
Views: | Downloads:
Download PDF
Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease
Amedeo LonardoAmedeo Lonardo, ... Ralf WeiskirchenRalf Weiskirchen
Open Access | Review | 14 Nov 2024
Views: | Downloads:
Download PDF
MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?
Christopher D. ByrneChristopher D. Byrne, Giovanni TargherGiovanni Targher
Open Access | Perspective | 26 Feb 2024
Views: | Downloads:
Download PDF

Coming soon.

Volume 6, Issue 2
Volume 6, Issue 1
Volume 5, Issue 4
Volume 5, Issue 3
Volume 5, Issue 2
Volume 5, Issue 1
Volume 4, Issue 4
Volume 4, Issue 3
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 4
Volume 3, Issue 3
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Volume 1, Issue 2
Volume 2, Issue 1
Volume 1, Issue 1
Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/metabolism-and-target-organ-damage

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/metabolism-and-target-organ-damage

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
Rss
© 2016-2026 OAE Publishing Inc., except certain content provided by third parties